旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02630 旺山旺水-B

已收盘 05-21 16:08:13

77.300

+0.550

+0.72%

最高78.050	最低72.000	成交量3.86万
今开76.950	昨收76.750	日振幅7.88%
总市值129.55亿	流通市值51.54亿	总股本1.68亿
成交额291.68万	换手率0.06%	流通股本6,668万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"旺山旺水-B","latestPrice":77.3,"timestamp":1779350893327,"preClose":76.75,"halted":0,"volume":38600,"delay":0,"changeRate":0.007166123778501591,"floatShares":66677100,"shares":167597800,"eps":-2.6826353273005052,"marketStatus":"已收盘","change":0.55,"latestTime":"05-21 16:08:13","open":76.95,"high":78.05,"low":72,"amount":2916810,"amplitude":0.078827,"askPrice":78,"askSize":1000,"bidPrice":77.3,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-2.7056622399811965,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":76.75,"openAndCloseTimeList":[[1779327000000,1779336000000],[1779339600000,1779350400000]],"volumeRatio":0.965,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02630","defaultTab":"news","newsList":[{"id":"1146506198","title":"旺山旺水-B 4月无新增发行及股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1146506198","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146506198?lang=zh_cn&edition=full","pubTime":"2026-05-07 06:46","pubTimestamp":1778107580,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年5月7日披露2026年4月证券变动月报。公告显示，截至2026年4月30日，公司H股股份数为66,677,133股，面值人民币1元，对应注册资本66,677,133元；非上市股份数为100,920,667股，对应注册资本100,920,667元。公司本月底法定/注册股本总额为人民币167,597,800元。报告期内，公司未发生新增发行、购回或注销股份情况，库存股份数维持为0股，股权激励计划与可换股票据等相关事务亦无发行或变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631637617","title":"旺山旺水-B(02630.HK)：拟取消监事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2631637617","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631637617?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:37","pubTimestamp":1777552623,"startTime":"0","endTime":"0","summary":"格隆汇4月30日丨旺山旺水-B(02630.HK)公告，公司拟取消公司监事会的设置并废止《苏州旺山旺水生物医药股份有限公司监事会议事规则》。监事会的职权由董事会审核委员会行使，公司各项规章制度中涉及监事会、监事的规定不再适用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260430/32195069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150860148","title":"苏州旺山旺水生物医药2025年收入大幅跃升至1.02亿元 创新药管线带动业务快速扩张 亏损同比扩大至3.57亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150860148","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150860148?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:29","pubTimestamp":1777552191,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于报告期内录得显著业绩增长和相应成本投入提升。根据年报披露，截至2025年12月31日止年度，公司实现营业收入约1.02亿元人民币，较2024年度的约0.12亿元人民币上涨约762.9%，主要动力来自核心创新药产品的商业化，以及持续的研发投入与市场拓展。管理层指出，2025年1月采用的受限制股份计划所计提费用约1.84亿元人民币，以及生产和市场费用约0.23亿元人民币为推动亏损扩大的主要原因。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"苏州旺山旺水生物医药2025年收入大幅跃升至1.02亿元 创新药管线带动业务快速扩张 亏损同比扩大至3.57亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126025375","title":"旺山旺水-B3月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1126025375","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126025375?lang=zh_cn&edition=full","pubTime":"2026-04-08 17:06","pubTimestamp":1775639209,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年4月8日发布了截至2026年3月31日的股份变动月报表。报告显示，公司本月未发生任何新增发行、回购或注销股份，整体股本维持稳定。苏州旺山旺水生物医药股份有限公司的已发行股本结构包括在香港联合交易所有限公司上市的H股66,677,133股，以及非上市股份100,920,667股。截至报告期末，上述股数均与上月底保持一致，公司注册股本总额为167,597,800股。本次月报由公司董事会秘书兼联席公司秘书郭婷签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510239","title":"15家企业同日递表港交所；香港中旅、旺山旺水发布2025年年度业绩丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510239","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624510239?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:10","pubTimestamp":1775059838,"startTime":"0","endTime":"0","summary":"15家企业同日递表港交所；香港中旅、旺山旺水发布2025年年度业绩丨港交所早参","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604023692388969.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604023692388969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1164","02630","BK1604","00308","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535160","title":"旺山旺水-B(02630)发布2025年度业绩，股东应占亏损3.56亿元，同比扩大68.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535160","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623535160?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:54","pubTimestamp":1774972457,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布截至2025年12月31日止年度业绩，收入1.02亿元(人民币，下同)，同比增长762.9%;公司拥有人应占亏损3.56亿元，同比扩大68.3%;每股基本亏损2.33元。截至2025年12月31日止年度，营业收入较上一年度实现大幅增长，核心增长动力来源于两部分：一是公司用于治疗男性勃起功能障碍的1类新药昂伟达® (产品代号：TPN171)于2025年7月获批上市后，市场推广和销售成效显著，收入快速增长;二是VV116干混悬剂的呼吸道合胞病毒(RSV)感染适应症License-out专案达成里程碑节点，顺利收到里程碑款项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"旺山旺水-B(02630)发布2025年度业绩，股东应占亏损3.56亿元，同比扩大68.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140467966","title":"一周港股牛熊榜 | 词元经济政策红利释放，迅策一周升28%；锂价暴涨，赣锋锂业升超27%；绩后暴跌引发IP依赖担忧，泡泡玛特暴跌29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140467966","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140467966?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:29","pubTimestamp":1774600142,"startTime":"0","endTime":"0","summary":"作为港股词元第一股，迅策凭借先发优势深度卡位。公司股价受此消息提振连升4日，累计涨幅近20%。本周泡泡玛特在业绩发布后的股价剧烈波动。旺山旺水本周下跌30.87%本周旺山旺水股价延续调整态势，周跌幅约10.7%，成交活跃度维持在较低水平。公司将于3月31日披露2025财年年报。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 | 词元经济政策红利释放，迅策一周升28%；锂价暴涨，赣锋锂业升超27%；绩后暴跌引发IP依...","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07489","03317","01772","09992","HSI","02442","HSImain","02630","HSTECH","01515","02477","02627","02706"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620295255","title":"旺山旺水－Ｂ(02630.HK)拟3月31日举行董事会会议考虑及批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620295255","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620295255?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:57","pubTimestamp":1773874622,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨旺山旺水－Ｂ(02630.HK)宣布，公司将于2026年3月31日(星期二)举行董事会会议，藉以(其中包括)考虑及批准集团截至2025年12月31日止年度的全年业绩及其发布，并考虑派发末期股息(如有)，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32079406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134238957","title":"旺山旺水-B（02630）2026年2月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1134238957","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134238957?lang=zh_cn&edition=full","pubTime":"2026-03-05 06:05","pubTimestamp":1772661947,"startTime":"0","endTime":"0","summary":"苏州旺山旺水生物医药股份有限公司于2026年3月5日发布截至2026年2月28日的股份变动月报表。报告显示，公司当月无新增发行、购回或注销股份，整体股本保持稳定。公司已发行H股数量维持为66,677,133股，面值1元人民币，总注册股本为人民币66,677,133元；非上市股份数量则维持在100,920,667股，面值同为1元人民币，对应注册股本人民币100,920,667元。截至报告期末，公司注册股本总额为人民币167,597,800元。本次月报由董事会秘书兼联席公司秘书郭婷签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616877332","title":"旺山旺水-B(02630)：H股股份奖励计划受托人变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2616877332","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616877332?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:49","pubTimestamp":1772455778,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，于2026年3月2日，为优化股份奖励计划管理效率及运作安排，公司建议变更公司于2026年2月9日采纳的股份奖励计划的受托人。股份奖励计划须经股东于股东特别大会上考虑及批准后生效。公司委聘嘉立信信托(香港)有限公司作为受托人，自2026年3月2日起生效，取代不再作为受托人的富途信托有限公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614706925","title":"旺山旺水-B02月24日主力净流入78万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2614706925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614706925?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920929,"startTime":"0","endTime":"0","summary":"02月24日, 旺山旺水-B股价涨1.16%，报收131.00元，成交金额1058.4万元，换手率0.12%，振幅3.09%，量比1.03。旺山旺水-B今日主力资金净流入78万元，上一交易日主力净流出0万元。该股近5个交易日上涨21.85%，主力资金累计净流入81.0万元；近20日主力资金累计净流入804.8万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161710a4c2225d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161710a4c2225d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613678731","title":"旺山旺水-B创上市新高 市值突破210亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2613678731","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613678731?lang=zh_cn&edition=full","pubTime":"2026-02-23 14:03","pubTimestamp":1771826604,"startTime":"0","endTime":"0","summary":"格隆汇2月23日丨旺山旺水-B(2630.HK)涨3.6%，报129.6港元，股价创上市新高，总市值217.21亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223145238a715241e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223145238a715241e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612625795","title":"旺山旺水-B创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2612625795","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612625795?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:52","pubTimestamp":1771552328,"startTime":"0","endTime":"0","summary":"格隆汇2月20日丨旺山旺水-B(02630.HK)涨4%，报124.8000港元，股价创历史新高，总市值209.16亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220095215a4b4f3e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260220095215a4b4f3e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611855174","title":"旺山旺水-B创上市新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2611855174","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611855174?lang=zh_cn&edition=full","pubTime":"2026-02-16 12:44","pubTimestamp":1771217041,"startTime":"0","endTime":"0","summary":"格隆汇2月16日丨旺山旺水-B(02630.HK)涨4.45%，报114.9000港元，股价创上市新高，总市值192.57亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216131409a4a980ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216131409a4a980ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610639371","title":"旺山旺水-B(02630)建议采纳H股股份奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2610639371","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610639371?lang=zh_cn&edition=full","pubTime":"2026-02-09 18:26","pubTimestamp":1770632774,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B(02630)发布公告，于2026年2月9日，董事会已议决建议采纳本公司股份奖励计划。股份奖励计划须经股东于股东特别大会上考虑及批准后生效。根据股份奖励计划，奖励所涉及的H股将于联交所购买及╱或透过场外交易取得。于该计划期间，根据股份奖励计划可授出的股份最高数目合共不得超过于采纳日期本公司已发行股份总数(不包括任何库存股份)的5.0%，即837.99万股H股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610657664","title":"旺山旺水-B02月09日主力净流入251.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610657664","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610657664?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624924,"startTime":"0","endTime":"0","summary":"02月09日, 旺山旺水-B股价涨2.94%，报收108.60元，成交金额1515.2万元，换手率0.21%，振幅8.34%，量比1.43。旺山旺水-B今日主力资金净流入251.6万元，上一交易日主力净流出0万元。该股近5个交易日上涨12.37%，主力资金累计净流入165.3万元；近20日主力资金累计净流入765.2万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161706a6e5364d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209161706a6e5364d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610664664","title":"旺山旺水-B创历史新高 市值逼近200亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664664","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610664664?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:14","pubTimestamp":1770603248,"startTime":"0","endTime":"0","summary":"格隆汇2月9日丨旺山旺水-B(02630.HK)涨8.63%，报114.6000港元，股价创历史新高，总市值192.07亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209101923a6e3fb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209101923a6e3fb1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606714763","title":"港股异动 | 旺山旺水-B(02630)回落近7% 昨日受尼帕疫情催化大涨近11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606714763","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606714763?lang=zh_cn&edition=full","pubTime":"2026-01-28 11:04","pubTimestamp":1769569485,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，旺山旺水-B回落近7%，昨日曾大涨近11%。截至发稿，跌6.89%，报101.4港元，成交额1109.93万港元。但值得注意的是，核苷类药物抑制尼帕病毒理论有一定的基础支持，这类病毒其实存在不同毒株，而这类药物对印度本次病毒疫情有多大作用，尚需临床考证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e15c8a706660d4fff69f6a1942e8617d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606917947","title":"武汉病毒研究所，有新发现","url":"https://stock-news.laohu8.com/highlight/detail?id=2606917947","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606917947?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:08","pubTimestamp":1769515722,"startTime":"0","endTime":"0","summary":"图源/央视新闻不过，中国科学院武汉病毒研究所官微披露，肖庚富/张磊砢研究员团队、单超研究员团队联合上海药物研究所、旺山旺水生物医药股份有限公司胡天文博士在国际期刊Emerging Microbes & Infections上发表了题为“The oral nucleoside drug VV116 is a promising candidate for treating Nipah virus infection”的重要研究成果，证实口服核苷类药物VV116对尼帕病毒具有显著的抗病毒活性，为这一高致死性新发传染病的防治带来新希望。尼帕病毒疫情持续发酵，带动市场对高致病性病毒检测领域的关注，IVD板块情绪升温。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127201438a6b30c9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127201438a6b30c9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","BK1161","BK1583","BK1515","BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123677388","title":"旺山旺水涨超12%，有研究发现VV116对尼帕病毒有治疗潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1123677388","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123677388?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:23","pubTimestamp":1769484234,"startTime":"0","endTime":"0","summary":"1月27日，$旺山旺水-B$涨超12%，高见112港元创上市新高，有研究发现VV116对尼帕病毒有治疗潜力。该成果首次证实VV116对尼帕病毒的治疗潜力，不仅可作为医护人员、实验室工作者等高危人群的预防性用药，更可为应对当下和未来的尼帕病毒疫情提供了一个现成的药物选择。公开资料显示，旺山旺水成立于2013年，重点布局神经精神、生殖健康和病毒感染三大治疗领域。","market":"hk","thumbnail":"https://static.tigerbbs.com/55450d779a02a0de3b93c078ca510ac6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/55450d779a02a0de3b93c078ca510ac6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e15c8a706660d4fff69f6a1942e8617d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vigonvita.cn","stockEarnings":[{"period":"1week","weight":-0.0466},{"period":"1month","weight":-0.1002},{"period":"3month","weight":-0.3604},{"period":"6month","weight":0.2792},{"period":"1year","weight":1.3},{"period":"ytd","weight":-0.0623}],"compareEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0395},{"period":"6month","weight":0.0171},{"period":"1year","weight":0.0832},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"苏州旺山旺水生物医药股份有限公司(简称“旺山旺水”)成立于2013年,是一家综合一体化的生物医药公司,致力于发现、开发和商业化创新小分子药物。公司致力于病毒感染、神经精神及生殖健康领域临床需求的满足。公司创始人团队来自中国科学院上海药物研究所,系药物开发领域的著名科学家,拥有逾20年的行业经验。高管团队平均拥有17年行业相关或专业管理经验。公司构建了覆盖“研究-临床开发-制造-商业化”全产业价值链的端到端能力。\n旺山旺水已形成极具竞争力且多元化的创新药产品管线。其中两项处于商业化或接近商业化阶段,四项处于临床阶段,三项处于临床前阶段。\nMindvy(研发代号:VV116)于2021年12月在乌兹别克斯坦获批上市,用于治疗中和重度新冠病毒感染。民得维(研发代号:VV116)于2023年1月获得中国国家药监局附条件批准上市,并于2025年1月由附条件批准转为常规批准,用于轻中度新冠病毒感染的治疗。VV116用于治疗呼吸道合胞病毒(RSV)感染的II期临床试验正在进行中。TPN171于2022年9月在乌兹别克斯坦获批上市,商品名为Onvita,于2025年7月在中国获批上市,商品名为昂伟达,获批适应症均为男性勃起功能障碍(ED)。\n旺山旺水已在江苏省连云港市建立符合GMP标准的商业化生产设施,总建筑面积约51,955平方米,年设计产能为100百万粒胶囊及600百万片片剂。\n旺山旺水拥有81项授权专利,获得国家高新技术企业、国家专精特新“小巨人”企业、江苏省科技型中小企业、江苏省潜在独角兽企业等荣誉。\n旺山旺水将继续秉持创新驱动发展理念,坚持创新,致力于为中国乃至全球所有患者的健康和生活质量的改善而努力。","exchange":"SEHK","name":"旺山旺水-B","nameEN":"VIGONVITA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"旺山旺水-B,02630,旺山旺水-B股票,旺山旺水-B股票老虎,旺山旺水-B股票老虎国际,旺山旺水-B行情,旺山旺水-B股票行情,旺山旺水-B股价,旺山旺水-B股市,旺山旺水-B股票价格,旺山旺水-B股票交易,旺山旺水-B股票购买,旺山旺水-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"旺山旺水-B(02630)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供旺山旺水-B(02630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}